Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

PHASE4TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Lidoderm

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine patch 5% or celecoxib 200 mg daily. Lidocaine patch 5% (Lidoderm®, Endo Pharmaceuticals Inc.), 1⅓ patches applied topically to each affected knee every 24 hours (q24h

DRUG

Celecoxib

Eligible patients were randomly allocated to receive one of two treatments for 12 weeks: lidocaine patch 5% or celecoxib 200 mg daily. Lidocaine patch 5% (Lidoderm®, Endo Pharmaceuticals Inc.), 1⅓ patches applied topically to each affected knee every 24 hours (q24h)

Trial Locations (20)

Unknown

Hueytown

Mesa

Oro Valley

Phoenix

Carlsbad

Daytona Beach

Gainesville

Inverness

Melbourne

Miami

Port Orange

Sarasota

Decatur

Marietta

New Orleans

Bingham Farms

Clemmons

Winston-Salem

Duncansville

Johnstown

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY